By focusing on mitochondria, the energy sources of cells,  the company seeks to target the fundamental causes of many age-related diseases in addition to mitochondrial conditions for which there are few effective treatments.

Totally Integrated Medicines Engine (TIME) is a unique development platform at Bactevo, which utilises microfluidics, nanofabrication and artificial intelligence to enhance drug discovery. In May 2018, Boeringher Ingelheim partnered with Bactevo for access to the platform.